Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c2080 |
|---|---|
| Identifier | NCT04002180 |
| Trial Title | Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease] |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab (Genetical Recombination) |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Tokyo |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2019-07-01 |
|---|---|
| Primary Completion Date | 2026-06-30 |
| Completion Date | 2026-06-30 |